Clinical trial

Closed-loop Control of Glucose Levels (Artificial Pancreas) During Postprandial Exercise in Adults With Type 1 Diabetes

NCT02855307

Drugs and interventions used in this trial

5 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

OTHER · Unmapped registry intervention 60-minute exercise Find medicine records · Find other trials using this name

DEVICE · Unmapped registry intervention Insulin pump Find medicine records · Find other trials using this name

DEVICE · Unmapped registry intervention Dexcom G4 Platinum glucose sensor Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Insulin Find medicine records · Find other trials using this name

OTHER · Unmapped registry intervention Single-hormone closed-loop strategy Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Closed-loop Control of Glucose Levels (Artificial Pancreas) During Postprandial Exercise in Adults With Type 1 Diabetes

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE2

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2016-09-01

PhasePHASE2

Conditions

Type 1 Diabetesverified · MONDO: type 1 diabetes mellitus

Interventions

60-minute exerciseOTHER

Insulin pumpDEVICE

Dexcom G4 Platinum glucose sensorDEVICE

InsulinDRUG

Single-hormone closed-loop strategyOTHER

Sponsors & collaborators

Institut de Recherches Cliniques de Montreallead sponsor

Mapped research locations

MontrealQuebec, Canada1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02855307 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.